Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new Locations section appears for the Philadelphia, PA site under Pennsylvania, replacing the old Pennsylvania Locations entry. The footer revision has been updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedPublications section wording updated to indicate entries are automatically filled from PubMed, and the page revision updated to v3.3.2.SummaryDifference0.1%

- Check52 days agoChange DetectedRemoved a general government funding/status notice that previously warned about possible updates and NIH operating status. This notice did not pertain to the study details, eligibility, or results on the page.SummaryDifference0.4%

- Check66 days agoChange DetectedMinimal layout and typography adjustments to the Study Details page with no changes to core content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check95 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference4%

- Check102 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.